http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018062837-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_799b6c8cb40ea97102dceda7bfe7b5c7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-248 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-235 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-248 |
| filingDate | 2017-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_133af5e4fcf751bf0cfb3ad2f5d0ae78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f3edd45a1a52b390ae92a5d624aa4bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17c6c563d3699392a76c7e6e1fa6330f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a87e6ab387bae4c79de666131d8999e |
| publicationDate | 2018-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2018062837-A1 |
| titleOfInvention | Chalcone derivative compound, optical isomer thereof, or pharmaceutically acceptable salt thereof, and pharmaceutical composition comprising same as effective ingredient for preventing or treating disease caused by reduction in mitochondrial oxygen consumption rate |
| abstract | The present invention relates to a chalcone derivative compound, an optical isomer thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an effective ingredient for preventing or treating diseases caused by reduction in a mitochondrial oxygen consumption rate. A pharmaceutical composition, when comprising the chalcone derivative compound, exerts excellent activity of increasing a mitochondrial oxygen consumption rate and can be usefully used for preventing or treating diseases caused by a reduction in the oxygen consumption rate of mitochondria, such as neurodegenerative diseases, attention deficit/hyperactivity disorder, schizophrenia, drug addiction, chronic renal failure, hepatic encephalopathy, and chronic liver disease. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110028421-A |
| priorityDate | 2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.